We are live on ! Find out more
Royce & Associates

Royce & Associates Portfolio holdings

AUM $12.4B Turnover 20.64%
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+0.11%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$14.3B
AUM Growth
-$743M
Cap. Flow
-$499M
Cap. Flow %
-3.49%
Top 10 Hldgs %
8.41%
Holding
1,329
New
83
Increased
398
Reduced
492
Closed
75
Avg Time Held
2.8 years
Top 10 Avg Time Held
1.1 years
Top 20 Avg Time Held
1.7 years

Top Sells

Rank Stock Value
1
MKSI icon
MKS Inc
MKSI
+$35.5M
2
WWD icon
Woodward
WWD
+$35M
3
CPRT icon
Copart
CPRT
+$22.9M
4
BGC icon
General Cable Corporation
BGC
+$22.7M
5
ORBK
Orbotech Ltd
ORBK
+$22.1M

Sector Composition

Rank Sector Weight
1 Industrials 29.74%
2 Technology 18.26%
3 Consumer Discretionary 14.92%
4 Financials 12.29%
5 Materials 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NDSN icon
201
Nordson
NDSN
$18B
$19.7M 0.14%
144,239
-111,380
-44% -$15.7M
2013 Q2
19 quarters
SAVE icon
202
DELISTED
Spirit Airlines, Inc.
SAVE
$19.3M 0.14%
511,432
-143,200
-22% -$6.01M
2016 Q1
8 quarters
ANGO icon
203
AngioDynamics
ANGO
$473M
$19.3M 0.14%
1,119,808
+20,991
+2% +$350K
2013 Q2
19 quarters
CRAY
204
DELISTED
Cray, Inc.
CRAY
$19.1M 0.13%
924,071
+357,308
+63% +$8.28M
2013 Q2
19 quarters
SHYF icon
205
DELISTED
The Shyft Group
SHYF
$19.1M 0.13%
1,108,981
-98,044
-8% -$1.53M
2013 Q2
19 quarters
ATHN
206
DELISTED
Athenahealth, Inc.
ATHN
$19.1M 0.13%
133,225
-10,280
-7% -$1.4M
2017 Q1
4 quarters
DCH icon
207
Dauch Corp
DCH
$1.15B
$18.9M 0.13%
1,244,145
+28,000
+2% +$460K
2016 Q4
5 quarters
TRS icon
208
TriMas Corp
TRS
$1.39B
$18.9M 0.13%
720,460
+81,500
+13% +$2.11M
2017 Q1
4 quarters
HRC
209
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$18.9M 0.13%
216,955
-146,655
-40% -$12.5M
2013 Q2
19 quarters
MDRX
210
DELISTED
Veradigm Inc. Common Stock
MDRX
$18.7M 0.13%
1,511,300
-118,300
-7% -$1.68M
2013 Q2
19 quarters
HTO icon
211
H2O America
HTO
$2.41B
$18.5M 0.13%
350,484
– –
2013 Q2
19 quarters
KRA
212
DELISTED
Kraton Corporation
KRA
$18.4M 0.13%
386,055
+23,970
+7% +$1.16M
2013 Q2
19 quarters
TRN icon
213
Trinity Industries
TRN
$2.01B
$18.3M 0.13%
780,257
-73,895
-9% -$1.82M
2013 Q2
19 quarters
GENC icon
214
Gencor Industries
GENC
$261M
$18.2M 0.13%
1,129,181
+232,922
+26% +$3.87M
2016 Q1
8 quarters
FSS icon
215
Federal Signal
FSS
$6.86B
$18.1M 0.13%
824,166
-115,300
-12% -$2.39M
2013 Q2
19 quarters
UNVR
216
DELISTED
Univar Solutions Inc.
UNVR
$18.1M 0.13%
653,539
-10,500
-2% -$309K
2015 Q4
9 quarters
BAS
217
DELISTED
Basis Energy Services, Inc.
BAS
$18.1M 0.13%
1,254,061
+208,789
+20% +$4.04M
2016 Q4
5 quarters
CBT icon
218
Cabot Corp
CBT
$3.84B
$18.1M 0.13%
324,721
– –
2013 Q2
19 quarters
SGRY icon
219
Surgery Partners
SGRY
$1.91B
$18.1M 0.13%
1,053,727
-4,941
-0.5% -$77K
2016 Q3
6 quarters
TSBK icon
220
Timberland Bancorp
TSBK
$354M
$18.1M 0.13%
594,189
+94,761
+19% +$2.72M
2013 Q2
19 quarters
FIX icon
221
Comfort Systems
FIX
$50.6B
$18M 0.13%
435,356
-78,835
-15% -$3.31M
2013 Q2
19 quarters
ALB icon
222
Albemarle
ALB
$11.3B
$17.9M 0.13%
192,866
-86,347
-31% -$9.51M
2013 Q2
19 quarters
HCCI
223
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$17.8M 0.12%
757,503
-30,464
-4% -$677K
2013 Q2
19 quarters
AEIS icon
224
Advanced Energy
AEIS
$9.53B
$17.8M 0.12%
277,803
+86,814
+45% +$6M
2013 Q2
19 quarters
AMN icon
225
AMN Healthcare
AMN
$1.57B
$17.7M 0.12%
312,609
-224,901
-42% -$12.2M
2016 Q4
5 quarters

Similar funds

Royce & Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Royce & Associates held 1,329 positions worth $14.3B, down 4.9% from $15B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

Royce & Associates withdrew a net $499M in Q1 2018, closing 75 positions and reducing 492 holdings. Its most notable exit was Sucampo Pharmaceuticals, Inc., an estimated $15.8M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 30% of assets, down from 30% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in PotlatchDeltic worth $12M.

  • Royce & Associates's largest Q1 2018 buy was PotlatchDeltic: 230,008 shares worth $12M.
  • Royce & Associates added most to Core Mark Holding Co., Inc. in Q1 2018, an estimated $24M increase.
  • Royce & Associates's biggest Q1 2018 reduction was MKS Inc, cutting an estimated $35.5M.
  • Royce & Associates fully exited Sucampo Pharmaceuticals, Inc. in Q1 2018, selling an estimated $15.8M.
  • Royce & Associates's ten largest holdings make up 8.4% of its $14.3B portfolio in Q1 2018.
  • Royce & Associates opened 83 new positions and closed 75 in Q1 2018.
  • Royce & Associates's portfolio value fell 4.9% quarter-over-quarter to $14.3B.

Based on Royce & Associates's 13F filing for Q1 2018, filed 14 May 2018.